March 04, 2015 6:04 PM ET


Company Overview of ZymoGenetics Inc.

Company Overview

ZymoGenetics Inc. develops and commercializes therapeutic proteins for the treatment of human diseases. It provides RECOTHROM Thrombin, a topical recombinant in the United States; PEG-Interferon lambda for treatment of hepatitis C virus infection; IL-21 for treatment of metastatic melanoma; and anti-IL-31 monoclonal antibody for treatment of atopic dermatitis. It offers research on discovery and advancement of therapeutic proteins with potential applications in immuno-oncology diseases. The company was formerly known as Zymos, Inc. and changed its name to ZymoGenetics Inc. in 1983. The company was founded in 1981 and is headquartered in Seattle, Washington. As of October 7, 2010, ZymoGenetic...

1201 Eastlake Avenue East

Seattle, WA 98102

United States

Founded in 1981

323 Employees

Key Executives for ZymoGenetics Inc.

Treasurer and Director
Vice President and Director
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Liventa Bioscience United States
Phylogix, Inc. United States
Gentis, Inc. United States
Ligandal Technology LLC United States
Appian Labs, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ZymoGenetics Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at